Contact
Contact page
Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.8
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
61 / 100 · ready · see similar
AI training policy
allowed
AI-bot protection
AI files
Evidence
llms.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
PT-141 (Bremelanotide): What the Approved Drug and Its Research Record Actually Show
Description
PT-141 is the research designation for bremelanotide, a central melanocortin receptor agonist FDA-approved for one indication. A plain digest of mechanism, the one approved use, and the off-label record.
Final URL
Language
en (html)
Scanned at
2026-06-24 03:40:57